Fecal microbiota transplant cost-effective for preventing CD
Use of fecal microbiota transplantation (FMT) is cost-effective for recurrent Clostridium difficile infection (CDI), according to a study published in the December issue of the Journal of Gastroenterology and Hepatology.

Gregory Merlo, from the Queensland University of Technology in Brisbane, Australia, and colleagues examined the cost-effectiveness of FMT compared with vancomycin for the treatment of recurrent CDI. A Markov model was developed to compare cost-effectiveness, with the structure of the model and choice of parameter values informed by a literature review of clinical evidence....

http://medicalxpress.com/news/2016-12-fecal-microbiota-transplant-cost-effective-cdi.html
Like
Comment
Share